3 ms·
"Synthetic" feels a bit like marketing, but the work is nonetheless cool. Venter's first "synthetic" bacterial cells had their nuclear genomes ejected and then
by echelon 8y ago
"Synthetic" feels a bit like marketing, but the work is nonetheless cool.
Venter's first "synthetic" bacterial cells had their nuclear genomes ejected and then replaced with genomes copied from pre-existing cells. It would be extraordinarily hard to create a cell from scratch without all of the existing biology ("to make an apple pie, first construct the universe".)
These genomes contain an abundance of genes, some of which are suspected to be inessential in maintenance of life and proliferation under normal conditions (ie. they signal pathways or encode structural or metabolic components that aren't absolutely critical).
Venter's work here is to identify a minimum viable set of genes required to run chosen from an existing, easy to grow bacteria. Such an organism (or set of organisms) would be much easier to study as there is less noise. The biochemistry gets much simpler.
To be clear, this isn't the minimum set of genes required to live. It's the minimum set of genes required to run the bacteria it is modeled after. Different experimental parameters may necessitate deriving similar minimal organisms from different species. Or introducing additional genes (eg. resistance genes).
Eventually, once these "synthetic" bacteria have been proven, labs will want to order them and conduct their experiments under these much "cleaner" experimental models.
- klyrs 8y ago> Such an organism (or set of organisms) would be much easier to study as there is less noise. The biochemistry gets much simpler. An article [1] was posted to HN a while back that gives me pause at that statement. Sometimes, perceived noise is signal and washing it out gets misleading results. Yes I'm sure this will make some experiments easier... but if it's for medical science... I have concerns. [1] https://www.theatlantic.com/science/archive/2019/01/cancer-culture-media-plasmax/579283/ https://www.theatlantic.com/science/archive/2019/01/cancer-c...